Sunshine Biopharma Inc
NASDAQ:SBFM

Watchlist Manager
Sunshine Biopharma Inc Logo
Sunshine Biopharma Inc
NASDAQ:SBFM
Watchlist
Price: 1.46 USD
Market Cap: 7.2m USD

Wall Street
Price Targets

SBFM Price Targets Summary
Sunshine Biopharma Inc

Wall Street analysts forecast SBFM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SBFM is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
315% Upside
Average
Price Target
6.12 USD
319% Upside
Highest
Price Target
6.3 USD
332% Upside
Sunshine Biopharma Inc Competitors:
Price Targets
CANTA
Cantargia AB
118% Upside
AMRN
Amarin Corporation PLC
14% Downside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
24% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
GNS
Genus PLC
15% Upside
ELIC
Elicera Therapeutics AB
46% Upside
688428
InnoCare Pharma Ltd
59% Upside
2142
Hbm Holdings Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Sunshine Biopharma Inc

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 2 years is 21%.

N/A
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Sunshine Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Sunshine Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SBFM's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for SBFM is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is Sunshine Biopharma Inc's Revenue forecast?
Projected CAGR
21%

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 2 years is 21%.

Back to Top